Published: August 1st 2025 | Updated: August 5th 2025
Clearside Biomedical's Xipere (triamcinolone acetonide injectable suspension) approved by Health Canada, among other company news
Published: August 4th 2025 | Updated: August 5th 2025
Retinal microvasculature on OCTA may predict coronary artery disease risk
Published: August 4th 2025 | Updated: August 5th 2025
Embracing dry eye
Published: August 1st 2025 | Updated: August 5th 2025
Monthly pipeline update: A July news roundup
Published: July 30th 2025 | Updated: August 5th 2025
Exonate plans to initiate phase 2b CLEAR-DE trial for EXN407 topical formulation for NPDR
Published: July 30th 2025 | Updated: August 5th 2025
National Vision awards scholarships to optometric students during NOA Convention 2025